{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:07:25Z","timestamp":1779966445338,"version":"3.53.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["311122"],"award-info":[{"award-number":["311122"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["318327"],"award-info":[{"award-number":["318327"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["333302"],"award-info":[{"award-number":["333302"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["333903"],"award-info":[{"award-number":["333903"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["01951"],"award-info":[{"award-number":["01951"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2822"],"award-info":[{"award-number":["2822"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004785","name":"NordForsk","doi-asserted-by":"publisher","award":["85352"],"award-info":[{"award-number":["85352"]}],"id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.biopha.2021.112501","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T01:11:27Z","timestamp":1638839487000},"page":"112501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration"],"prefix":"10.1016","volume":"146","author":[{"given":"Laura","family":"Hellinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Vattulainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Liukkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Treyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Handin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"My\u00f6h\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Poso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Artursson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112501_bib1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.biopha.2021.112501_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890600946724","article-title":"Age-related macular degeneration--emerging pathogenetic and therapeutic concepts","volume":"38","author":"Gehrs","year":"2006","journal-title":"Ann. Med."},{"key":"10.1016\/j.biopha.2021.112501_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002512-200219020-00003","article-title":"Age-related macular degeneration: epidemiology and optimal treatment","volume":"19","author":"La Cour","year":"2002","journal-title":"Drugs Aging"},{"key":"10.1016\/j.biopha.2021.112501_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2021.112501_bib5","doi-asserted-by":"crossref","first-page":"ORSF68","DOI":"10.1167\/iovs.13-12757","article-title":"Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging","volume":"54","author":"Bowes Rickman","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112501_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","article-title":"Risk factors and biomarkers of age-related macular degeneration","volume":"54","author":"Lambert","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2021.112501_bib7","first-page":"32","article-title":"Oxidative damage and age-related macular degeneration","volume":"5","author":"Winkler","year":"1999","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2021.112501_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4161\/auto.24546","article-title":"Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration","volume":"9","author":"Kaarniranta","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2021.112501_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1083\/jcb.201709072","article-title":"Pathways of cellular proteostasis in aging and disease","volume":"217","author":"Klaips","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2021.112501_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2021.112501_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10565-016-9371-8","article-title":"Autophagy regulates death of retinal pigment epithelium cells in age-related macular degeneration","volume":"33","author":"Kaarniranta","year":"2017","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.biopha.2021.112501_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-291X(80)80179-3","article-title":"Catabolism of neuropeptides by a brain proline endopeptidase","volume":"94","author":"Taylor","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.112501_bib13","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1021\/jm901104g","article-title":"Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors","volume":"53","author":"Lawandi","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.112501_bib14","doi-asserted-by":"crossref","unstructured":"Lopez A., Tarrago T., Giralt E. Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010. Expert Opin Ther Pat 2011; 21: 1023\u20131044.","DOI":"10.1517\/13543776.2011.577416"},{"key":"10.1016\/j.biopha.2021.112501_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1471-4159.1983.tb11815.x","article-title":"Inhibition of rabbit brain prolyl endopeptidase by n-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitor","volume":"41","author":"Wilk","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.112501_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bcp.2019.01.013","article-title":"New tricks of prolyl oligopeptidase inhibitors \u2013 a common drug therapy for several neurodegenerative diseases","volume":"161","author":"Svarcbahs","year":"2019","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2021.112501_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.04.003","article-title":"The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","volume":"68","author":"Savolainen","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2021.112501_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104558","article-title":"Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A","volume":"151","author":"Svarcbahs","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.112501_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110253","article-title":"The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy","volume":"128","author":"Kilpel\u00e4inen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.112501_bib20","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1111\/j.1582-4934.2008.00577.x","article-title":"Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells","volume":"13","author":"Ryh\u00e4nen","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2021.112501_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069563","article-title":"Autophagy activation clears ELAVL1\/HuR-mediated accumulation of SQSTM1\/p62 during proteasomal inhibition in human retinal pigment epithelial cells","volume":"8","author":"Viiri","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2021.112501_bib22","first-page":"1399","article-title":"P62\/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells","volume":"16","author":"Viiri","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2021.112501_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2021.112501_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2012.01846.x","article-title":"A prolyl oligopeptidase inhibitor, KYP-2047, reduces alpha-synuclein protein levels and aggregates in cellular and animal models of Parkinson\u2019s disease","volume":"166","author":"My\u00f6h\u00e4nen","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112501_bib25","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/ac504689z","article-title":"Fast and sensitive total protein and peptide assays for proteomic analysis","volume":"87","author":"Wi\u015bniewski","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biopha.2021.112501_bib26","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/ac300006b","article-title":"Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis","volume":"84","author":"Wi\u015bniewski","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biopha.2021.112501_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jprot.2014.07.012","article-title":"Multi-enzyme digestion FASP and the \u2018total protein approach\u2019-based absolute quantification of the Escherichia coli proteome","volume":"109","author":"Wi\u015bniewski","year":"2014","journal-title":"J. Proteom."},{"key":"10.1016\/j.biopha.2021.112501_bib28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2021.112501_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2021.112501_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","article-title":"Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)","volume":"14","author":"Mi","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2021.112501_bib31","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1093\/nar\/gkw880","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Vizca\u00edno","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2021.112501_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1006\/bbrc.1999.0366","article-title":"S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase","volume":"257","author":"Barelli","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.112501_bib33","unstructured":"Gynther J., M\u00e4nnist\u00f6 P.T., Wall\u00e9n E., Christaans H., Forsberg M., Poso A., et al. Compounds Having Prolyl Oligopeptidase Inhibitory Activity 2004."},{"key":"10.1016\/j.biopha.2021.112501_bib34","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.bmc.2006.12.036","article-title":"2(S)-(Cycloalk-1-enecarbonyl)-1-(4-phenyl-butanoyl)pyrrolidines and 2(S)-(aroyl)-1-(4-phenylbutanoyl)pyrrolidines as prolyl oligopeptidase inhibitors","volume":"15","author":"Jarho","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2021.112501_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112501_bib36","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2021.112501_bib37","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1021\/acschembio.8b00270","article-title":"Detection of chemical engagement of solute carrier proteins by a cellular thermal shift assay","volume":"13","author":"Hashimoto","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biopha.2021.112501_bib38","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/mp4000822","article-title":"Rapid measurement of intracellular unbound drug concentrations","volume":"10","author":"Mateus","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2021.112501_bib39","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1021\/jm401963n","article-title":"A high-throughput cell-based method to predict the unbound drug fraction in the brain","volume":"57","author":"Mateus","year":"2014","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2021.112501_bib40","doi-asserted-by":"crossref","first-page":"C328","DOI":"10.1152\/ajpcell.1999.276.2.C328","article-title":"Functional interaction of the K-Cl cotransporter (KCC1) with the Na-K-Cl cotransporter in HEK-293 cells","volume":"276","author":"Gillen","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2021.112501_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1)","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2021.112501_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/ijms20010210","article-title":"Interplay between autophagy and the ubiquitin-proteasome system and its role in the pathogenesis of age-related macular degeneration","volume":"20","author":"Blasiak","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112501_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100858","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2021.112501_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcell.2018.00128","article-title":"Crosstalk between mammalian autophagy and the ubiquitin-proteasome system","volume":"6","author":"Kocaturk","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2021.112501_bib45","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.3390\/ijms20163896","article-title":"Causative links between protein aggregation and oxidative stress: a review","volume":"20","author":"L\u00e9vy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112501_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2021.112501_bib47","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1080\/15548627.2017.1358851","article-title":"Pathway choice between proteasomal and autophagic degradation","volume":"13","author":"Lu","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2021.112501_bib48","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1167\/iovs.07-1352","article-title":"Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration","volume":"49","author":"Nordgaard","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112501_bib49","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.17219\/acem\/27093","article-title":"The dry form of age-related macular degeneration (AMD): the current concepts of pathogenesis and prospects for treatment","volume":"24","author":"Zajac-Pytrus","year":"2015","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2021.112501_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/aos.12185","article-title":"Stem cell-based treatment in geographic atrophy: promises and pitfalls","volume":"92","author":"Kvanta","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112501_bib51","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112501_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuint.2011.12.010","article-title":"The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum","volume":"60","author":"Jalkanen","year":"2012","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.biopha.2021.112501_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255784","article-title":"Tracking cancer drugs in living cells by thermal profiling of the proteome","volume":"346","author":"Savitski","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112501_bib54","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nprot.2015.101","article-title":"Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry","volume":"10","author":"Franken","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2021.112501_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12953-017-0122-4","article-title":"Thermal proteome profiling: unbiased assessment of protein state through heat-induced stability changes","volume":"15","author":"Mateus","year":"2017","journal-title":"Proteome Sci."},{"key":"10.1016\/j.biopha.2021.112501_bib56","article-title":"Pharmacokinetic aspects of retinal drug delivery","author":"Del Amo","year":"2016","journal-title":"Prog. Retin. Eye Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221012877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221012877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:43:06Z","timestamp":1779964986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221012877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":56,"alternative-id":["S0753332221012877"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112501","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112501"}}